Dysphagia Knowledge Hub — 吞嚥困難知識庫

Multiple System Atrophy and Dysphagia — Clinical Guide to Swallowing Problems in MSA

TL;DR: Multiple system atrophy (MSA) is a rare, rapidly progressive parkinsonism in which swallowing problems appear early and severely — often within five years of the first motor symptom. Up to two-thirds of patients show penetration or aspiration on instrumental testing, aspiration pneumonia is a leading cause of death, and there is no disease-modifying treatment. Management is therefore about early instrumental assessment (VFSS or FEES), compensatory strategies, IDDSI-based diet modification, and protecting the airway — including watching for the dangerous nighttime breathing sound called stridor.

What Is Multiple System Atrophy?

Multiple system atrophy is a rare neurodegenerative disease that damages several body systems at once — movement, balance, blood-pressure control, bladder function, and swallowing. It belongs to a family of conditions called atypical parkinsonisms because it looks like Parkinson’s disease at first but progresses faster and responds poorly to levodopa.

MSA is caused by abnormal clumps of a protein called alpha-synuclein building up inside the brain’s support cells (glial cells), rather than inside nerve cells as in Parkinson’s disease. This difference explains why MSA advances more aggressively and why standard Parkinson’s drugs usually fail.

Key numbers:

• Prevalence: roughly 3–5 people per 100,000 — genuinely rare
• Typical onset: mid-50s (rare before 40 or after 75)
• Median survival: about 6–10 years from first symptom
• Two main types: MSA-P (parkinsonian — slowness and stiffness dominate) and MSA-C (cerebellar — balance and coordination problems dominate)

Because MSA is rare and mimics Parkinson’s disease, diagnosis is often delayed by two to three years. Swallowing assessment matters here: dysphagia that appears early and progresses fast is one of the clinical clues that separates MSA from ordinary Parkinson’s disease.

Why Swallowing Fails Early in MSA

Swallowing is one of the most complex actions the body performs — more than 30 muscles and five cranial nerves must fire in a sequence lasting about one second. MSA damages the brainstem and cerebellar circuits that coordinate this sequence, so the swallow breaks down at several points at once.

The 2021 international consensus statement on dysphagia in MSA (a panel of movement-disorder and swallowing specialists, published in Parkinsonism & Related Disorders) reached several conclusions that every caregiver should know:

1. Dysphagia typically appears within five years of motor onset — much earlier than in Parkinson’s disease, where serious swallowing problems usually take a decade or more.
2. Dysphagia is associated with shorter survival.
3. Aspiration pneumonia is a recognized cause of death in MSA.
4. Instrumental assessment (VFSS or FEES) is recommended at diagnosis and periodically afterward — not just when the patient starts coughing.
5. No treatment has been proven to reverse MSA dysphagia, so compensatory strategies and diet modification are the mainstays.

This last point is what makes MSA different from conditions like myasthenia gravis (where medication can restore swallowing) or stroke (where the brain can partially rewire). In MSA, the goal is to stay ahead of a moving target — adjusting the diet and mealtime routine as the disease progresses.

What Instrumental Tests Show

Two tests let clinicians see the swallow directly: VFSS (videofluoroscopic swallowing study — an X-ray movie of swallowing, also called a modified barium swallow) and FEES (fiberoptic endoscopic evaluation of swallowing — a small camera passed through the nose to watch the throat).

VFSS findings

A 2018 study of 59 MSA patients found abnormalities even in early disease:

• Vallecular residue (food left pooling in a pocket above the voice box): 89.8% — the most common finding
• Penetration or aspiration (material entering the airway): 67.8%
• Pharyngeal wall coating (a film of food clinging to the throat after the swallow): 66.1%

The MSA-P subtype showed more swallowing apraxia (difficulty organizing the movement) and more vallecular residue than MSA-C.

FEES findings

A 2023 FEES study of 25 MSA patients painted a similar picture:

• Delayed pharyngeal phase (the throat swallow triggers late): 92%
• Posterior oral incontinence (food leaking into the throat before the swallow is ready): 52%
• Penetration: more frequent with liquids — 68%
• Aspiration: occurred only with liquids — 20%
• Vocal fold motion impairment: 56% — a distinctly MSA feature (see stridor below)

The consistent message across studies: thin liquids are the most dangerous consistency in MSA, because they move fast and slip into a slowly-triggering, weakly-protected airway. This is exactly the situation IDDSI thickened-fluid levels were designed for.

Who Is at Highest Risk of Aspiration?

A 2025 cross-sectional study of 105 MSA patients found that 26.7% aspirated on videofluoroscopy, and identified a practical bedside predictor: the Barthel Index (BI), a standard 0–100 measure of daily-living independence.

• Each 10-point drop in BI was associated with a 20–23% increase in aspiration prevalence.
• A BI cutoff of 67.5 identified aspiration risk with 86% sensitivity and 69% specificity — a useful rule of thumb for when to push for a formal swallowing evaluation.
• The association was strongest in the MSA-P subtype.

A separate 2022 study linked pneumonia risk to the Nishimura Dysphagia Severity Scale (NdSSS) stage and the MSA-P subtype, reinforcing that aspiration prevention must start early — not after the first chest infection.

Caregiver translation: if a person with MSA is becoming less independent in daily activities — needing help dressing, transferring, or walking — their swallow is very likely declining in parallel. That is the moment to request a VFSS or FEES referral, even if mealtimes still “look fine.” Silent aspiration (aspiration without coughing) is common in neurodegenerative disease.

Stridor — The MSA Emergency Sign Families Must Know

MSA has one swallowing-and-airway feature that is almost unique among the parkinsonisms: vocal fold motion impairment, which can produce stridor — a harsh, high-pitched, snoring-like sound when breathing in, caused by the vocal cords failing to open properly.

Over half of MSA patients in the FEES study had vocal fold motion impairment. Stridor often appears at night first (partners notice a new, raspy breathing sound during sleep) and can progress to dangerous airway narrowing. It is a recognized cause of sudden death in MSA and must never be dismissed as “just snoring.”

What to do:

• Report any new inspiratory breathing noise to the neurologist promptly — daytime stridor is a red-flag emergency.
• CPAP at night (pressures around 5–10 mbar) is the first-line treatment for laryngeal stridor and is non-invasive.
• Botulinum toxin injections into the vocal-cord adductor muscles are an option for stridor — but the consensus guidance is that they should be restricted to patients without significant dysphagia, because weakening those muscles can worsen swallowing protection.
• Severe, unresponsive stridor may require tracheostomy.

Any new stridor should also trigger a fresh swallowing review — the same vocal-cord weakness that narrows the airway for breathing also weakens its protection during swallowing.

Managing Eating and Drinking Day to Day

Because no drug reverses MSA dysphagia, management is compensatory. The consensus statement recommends the standard toolkit — which maps directly onto the IDDSI framework this hub documents:

Diet texture modification (IDDSI):

• Thin liquids first. Given that aspiration in MSA occurs predominantly with liquids, a speech-language pathologist will often trial IDDSI Level 1 (slightly thick) or Level 2 (mildly thick) fluids early, verified with the IDDSI Flow Test.
• Solids follow function. As pharyngeal residue and delayed triggering worsen, diets typically step down through IDDSI Level 6 (soft & bite-sized) → Level 5 (minced & moist) → Level 4 (puréed). Each transition should be guided by repeat instrumental assessment, not guesswork.
• Moist, cohesive textures (the Level 5 profile) tend to clear the valleculae better than dry, crumbly, or sticky foods — directly addressing the most common VFSS finding in MSA.

Swallowing maneuvers and postures:

• Chin tuck can help when the pharyngeal swallow is delayed.
• Effortful swallow and small, deliberate boluses reduce residue.
• Slowing the pace — smaller sips and bites, alternating liquids and solids, allowing double swallows — compensates for the disorganized sequence.

Mealtime environment:

• Fully upright seating (90°), supervised meals, and no eating when drowsy — MSA patients often have severe autonomic dysfunction and sleep disorders that make fatigue-related aspiration a real risk.
• Meticulous oral hygiene reduces the bacterial load of whatever is aspirated; the evidence base for oral care cutting aspiration pneumonia comes from the classic Yoneyama 2002 randomized trial in Japanese care homes.

Medication considerations:

• A levodopa trial is still recommended in MSA — up to about 30% of patients get some motor benefit, and a structured FEES-levodopa test can show whether swallowing improves on medication.
• Review the full medication list with the neurologist: sedatives and anticholinergics (often prescribed for MSA’s bladder symptoms and drooling) can worsen swallowing and dry the mouth — see our companion article on drug-induced dysphagia.

The Tube-Feeding Conversation

The consensus statement is honest about the limits of evidence here: percutaneous endoscopic gastrostomy (PEG) may be considered when dysphagia is severe enough to threaten nutrition or cause recurrent aspiration pneumonia, but its impact on survival in MSA is undetermined.

Practical points for families:

• A PEG does not eliminate aspiration risk — saliva aspiration continues, and refluxed tube feeds can also be aspirated. Oral care and positioning remain essential.
• Many MSA patients with PEGs continue pleasure oral intake of safe textures (decided with the SLP) — feeding tubes and eating are not mutually exclusive.
• Because MSA progresses, the decision should be revisited at regular intervals rather than treated as one-way. Advance care planning conversations — about PEG, tracheostomy, and end-of-life wishes — are best held early, while the patient can still communicate clearly, since MSA also impairs speech.

How MSA Dysphagia Differs From Parkinson’s Disease

This distinction matters clinically, because families are often told “it’s Parkinson’s” for years before the diagnosis is revised:

Feature	Parkinson’s disease	Multiple system atrophy
Serious dysphagia onset	Usually 10+ years into disease	Often within 5 years of onset
Levodopa response of swallow	Often partially responsive	Usually poor (≤30% any benefit)
Vocal fold paralysis / stridor	Rare	Common (≈50%+); can be life-threatening
Progression speed	Slow	Rapid
Aspiration pneumonia as cause of death	Common in late disease	Common, and earlier

The practical takeaway: early, severe, fast-worsening dysphagia — especially with stridor, early falls, or blood-pressure drops — should prompt specialist review for MSA, and a lower threshold for instrumental swallowing assessment.

Common Mistakes and Pitfalls

1. Waiting for coughing before referring. Silent aspiration is common; by the time coughing at meals is obvious, aspiration has usually been present for months. Use the Barthel Index trend as a trigger instead.
2. Thickening everything without assessment. Over-thickening fluids worsens residue in a throat that already clears poorly — the right IDDSI level must come from VFSS/FEES, not habit.
3. Dismissing nighttime breathing noise as snoring. New stridor in MSA is a medical urgency.
4. Botulinum toxin for stridor without checking swallowing first. It can unmask or worsen dysphagia.
5. Treating PEG as a cure for aspiration pneumonia. It reduces food aspiration but not saliva aspiration; oral care and positioning remain the foundation.
6. Assuming “Parkinson’s timeline.” Families using Parkinson’s disease expectations under-prepare for how quickly MSA swallowing deteriorates — plan diet-level reviews every few months, not yearly.
7. Skipping advance care planning until speech fails. MSA takes the voice early; hold the PEG/tracheostomy/end-of-life conversations while communication is still possible.

When to Seek Urgent Help

• New harsh breathing sound when inhaling (especially if present during the day) — same-day medical review
• Choking episode with prolonged coughing, blueness, or inability to clear the airway — emergency services
• Fever, new chest congestion, or sudden decline after meals — possible aspiration pneumonia
• Rapid weight loss or visible dehydration — urgent dietitian/SLP review

Citations and Sources

1. Dysphagia in multiple system atrophy — consensus statement on diagnosis, prognosis and treatment — International consensus conference, Parkinsonism & Related Disorders (2021). The anchor guideline for this article: dysphagia within 5 years of motor onset, VFSS/FEES at diagnosis and periodically, compensatory strategies as mainstay, PEG survival impact undetermined. ScienceDirect S1353802021001206
2. Swallowing Characteristics in Patients with Multiple System Atrophy Analyzed Using FEES Examination — Dysphagia (2023), 25 patients: 92% delayed pharyngeal phase, 68% penetration with liquids, 20% aspiration (liquids only), 56% vocal fold motion impairment. Springer 10.1007/s00455-023-10619-5
3. Characteristics of Early Oropharyngeal Dysphagia in Patients with Multiple System Atrophy — VFSS study of 59 patients: 89.8% vallecular residue, 67.8% penetration/aspiration, 66.1% pharyngeal coating; MSA-P vs MSA-C differences. PubMed 29621788
4. Clinical measures associated with aspiration risk in multiple system atrophy: a cross-sectional study — 105 patients, 26.7% aspiration on VFSS; Barthel Index cutoff 67.5 (86% sensitivity / 69% specificity); each 10-point BI drop → 20–23% higher aspiration prevalence. PMC12590134
5. Relationship Between Pneumonia and Dysphagia in Patients With Multiple System Atrophy — Frontiers in Neurology (2022): NdSSS stage and MSA-P subtype as pneumonia risk factors; aspiration prevention needed from early stages. 10.3389/fneur.2022.904852
6. The Shaking Palsy of the Larynx — Potential Biomarker for Multiple System Atrophy — Frontiers in Neurology (2019): laryngeal findings in MSA; CPAP first-line for stridor (5–10 mbar), botulinum toxin restricted to patients without dysphagia, levodopa trial rationale. 10.3389/fneur.2019.00241
7. Prevalence of multiple system atrophy: A literature review — Neuroepidemiology-reviewed prevalence estimate of ~3–5 per 100,000. PubMed 38453600
8. Multiple system atrophy — Practical Neurology (BMJ, 2023): clinical overview of MSA-P/MSA-C phenotypes, natural history, median survival 6–10 years, red-flag features separating MSA from Parkinson’s disease. pn.bmj.com/content/23/3/208
9. High Resolution Manofluorographic Study in Patients With Multiple System Atrophy — Frontiers in Medicine (2018): early upper esophageal sphincter and proximal esophageal abnormalities detectable by manometry. 10.3389/fmed.2018.00286
10. The effect of oral hygiene on pneumonia in institutionalized elderly (Yoneyama 2002) — Randomized trial showing professional oral care reduces aspiration pneumonia risk; the evidence base for oral-hygiene recommendations in neurodegenerative dysphagia. PubMed 11943036

This article paraphrases publicly-available clinical guidelines and primary research. For clinical practice, refer to the current official documentation from your neurologist, movement-disorder specialist, or speech-language pathologist. This page is not medical advice.

---

Last updated: 2026-10-08 · License: CC BY 4.0 · Maintained by SeniorDeli (Carewells) — a Hong Kong social enterprise producing IDDSI-compliant care food for people living with dysphagia. This page is educational only; see About for our clinical partners and social mission.